AIDrugApp: Artificial Intelligence-based Web-App for Virtual Screening of Inhibitors against SARS-COV-2

02 December 2020, Version 1
This content is a preprint and has not undergone peer review at the time of posting.

Abstract

Currently, there is no effective cure for SARS-COVID-19 diseases. The identification of novel therapeutic targets and drug-like compounds is required for the development of anti-COVID-19 drugs. Virtual screening is currently the most significant component for identifying drug-like molecules from large datasets for drug design and development. But there are no effective easily available and user-friendly applications for virtual screening of drug leads against SARS-COV-2. Therefore, we have developed a user-friendly web-app named “AIDrugApp” for the virtual screening of inhibitor molecules against SARS-CoV-2. AIDrugApp is a novel open-access, deep learning AI-based inhibitory activity prediction and data statistics visualization platform. Users can predict the inhibitory activities (Active/ Inactive) and pIC-50 values of new compounds against SARS-CoV-2 replicase polyprotein, 3CLpro and human angiotensin-converting enzymes. It is also useful for virtual screening of chemical features of molecules towards SARS-COVID-19 clinical trial bioactivities. This paper presents the development and architecture of AIDrugApp. We also present two case studies where large sets of molecules were screened by our app. Screened molecules were analyzed further by molecular docking and ADME analysis to identify the potential drug candidates.

Web-App URL: https://sars-covid-app.herokuapp.com/

Keywords

deep neural network
Web-app
virtual screening
SARS-COV-2
data analysis
molecular docking
ADME
multiple layer perceptron
drug designing

Supplementary materials

Title
Description
Actions
Title
S1
Description
Actions
Title
S2
Description
Actions
Title
S3
Description
Actions
Title
S4
Description
Actions

Comments

Comments are not moderated before they are posted, but they can be removed by the site moderators if they are found to be in contravention of our Commenting Policy [opens in a new tab] - please read this policy before you post. Comments should be used for scholarly discussion of the content in question. You can find more information about how to use the commenting feature here [opens in a new tab] .
This site is protected by reCAPTCHA and the Google Privacy Policy [opens in a new tab] and Terms of Service [opens in a new tab] apply.